Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.86 SEK | -0.20% | +4.01% | -12.12% |
Feb. 06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 | |
Feb. 06 | Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024 |
Sales 2024 * | 580M 52.88M | Sales 2025 * | 620M 56.57M | Capitalization | 384M 35M |
---|---|---|---|---|---|
Net income 2024 * | 28M 2.55M | Net income 2025 * | 41M 3.74M | EV / Sales 2024 * | 0.8 x |
Net Debt 2024 * | 77.93M 7.11M | Net Debt 2025 * | 75.63M 6.9M | EV / Sales 2025 * | 0.74 x |
P/E ratio 2024 * |
13.3
x | P/E ratio 2025 * |
9.17
x | Employees | 200 |
Yield 2024 * |
2.07% | Yield 2025 * |
3.44% | Free-Float | 61.67% |
Latest transcript on Boule Diagnostics AB
1 day | -2.23% | ||
1 week | +3.35% | ||
Current month | -0.50% | ||
1 month | -0.70% | ||
3 months | -16.27% | ||
6 months | +9.17% | ||
Current year | -11.94% |
Managers | Title | Age | Since |
---|---|---|---|
Holger Lembrér
DFI | Director of Finance/CFO | - | Dec. 31 |
Sales & Marketing | - | 21-09-30 | |
Aishat Bislieva
HRO | Human Resources Officer | - | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 15-12-31 | |
Chairman | 72 | 20-12-31 | |
Director/Board Member | 57 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 9.86 | -0.20% | 302 |
24-04-18 | 9.88 | +3.35% | 11,066 |
24-04-17 | 9.56 | -0.21% | 1,013 |
24-04-16 | 9.58 | +1.48% | 20,871 |
24-04-15 | 9.44 | -0.42% | 4,404 |
Delayed Quote Nasdaq Stockholm, April 18, 2024 at 11:24 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.94% | 35.12M | |
+2.02% | 207B | |
+2.17% | 175B | |
+10.45% | 132B | |
+16.62% | 99.1B | |
-4.26% | 60.89B | |
+13.38% | 52.04B | |
-6.33% | 45.48B | |
-4.74% | 38.81B | |
+9.89% | 38.77B |
- Stock Market
- Equities
- BOUL Stock